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Abstract
This paper reviews the two leading methods used to project the
number of AIDS cases: back calculation and extrapolation. These
methods are assessed in light of key features of the HIV/AIDS
epidemic and of data on the epidemic; they are also assessed in
terms of the quality of the projections they yield.
Our analysis shows that both methods have tended to
overproject, often by sizable amounts, the number of AIDS cases
in the U.S., especially among homosexual/bisexual males and users
of blood and blood products. Our results provide no evidence
that the use of AZT and other prophylaxis accounts for these
projection errors. Rather, the overprojections appear to be
mainly the result of a considerable reduction in the rate of new
HIV infection among the gay community starting in 1983-85.
A new method for projecting AIDS cases is proposed that
exploits knowledge about the process generating AIDS cases and
that incorporates readily available information about rates of
new HIV infection. This method is far less sensitive to
estimates of the incubation distribution than the method of back
calculation and is shown, for the two transmission categories
studied, to generate far more accurate AIDS case projections
through 1990 than those based on the method of extrapolation.
Relative to the method of extrapolation, this method projects
22,000 fewer new AIDS cases for 1995 (a 36 percent difference).
This method also projects that intravenous drug users will
replace homosexual/bisexual men as the dominant transmission
category for AIDS.
Projecting the Number of New AIDS Cases in the U.S.
Between 1981 and 1989 the reported number of deaths from AIDS in the U.S.
increased by roughly two orders of magnitude. In total, over 80,000 Americans
are reported to have died of AIDS during the 1980s (Centers for Disease Control,
1992). Although this total represents less than 1/2 of 1 percent of all deaths
in the U.S. during that decade, the sharp rate of increase has provoked great
fears of massive numbers of future deaths due to AIDS. Indeed, early
projections from the Centers for Disease Control (CDC) indicated that cumulative
totals of 270,000 AIDS cases and 180,000 AIDS deaths would occur by the end of
1991 (Public Health Service, 1986).
In combination with the actual rise in AIDS mortality, the large numbers of
projected AIDS cases and AIDS deaths have lead to major responses among
individuals, employers, hospitals, insurance companies, and public policymakers.
Rates of sexual behavior that increase the risk of HIV infection appear to have
declined, at least among certain groups (see Becker and Joseph, 1988). Many
hospital systems have expanded their capacity to deal with HIV/AIDS on both an
inpatient and an outpatient basis (see Hendrix, 1987 and Volberding, 1987).
Insurance companies have established coverage limits and now typically require
negative HIV tests as a precondition for certain types and amounts of individual
coverage (see Eden, 1988 and MetLife, 1990). Public policymakers have increased
funding for biomedical research related to the detection, prevention, and
treatment of HIV infection, mounted campaigns to educate the public about
HIV/AIDS, and implemented legislation to protect individuals from AIDS-related
discrimination in housing and labor markets (see Rhein, 1990 and Rayhawk, 1991).
Policymakers have also devoted considerable resources to the care of HIV-
infected individuals.
Given the wide range of costly social, legal, and economic adjustments that
have been made at least partly on the basis of widely-publicized AIDS case
projections, a critical review of the methods used to calculate those
projections seems well in order. Section I describes the two most-widely used
techniques for projecting AIDS cases: extrapolation and back calculation.
Section II describes key data imperfections that may affect the quality of the
projections these techniques yield. These imperfections include delays in the
reporting of AIDS cases to the CDC, changes in the official criteria used to
define an AIDS case, and incomplete reporting to the CDC of individuals who have
been diagnosed as having AIDS. Refinements of the two basic projection methods
to account for these data imperfections, which has been the main focus of the
statistical literature in this area, are also discussed in this section.
Section III provides an empirical assessment of the two techniques by comparing
previously-constructed projections of the incidence of AIDS (for the entire U.S.
population) to each other as well as to actual data on the incidence of AIDS.
We find that most researchers have over-projected, often by sizable
amounts, the number of AIDS cases subsequently recorded in the U.S.,
particularly for certain transmission categories. Recent studies have argued
that advances in the medical treatment of HIV/AIDS can potentially explain these
projection errors (see Gail, Rosenberg, and Goedert, 1990). We test this view
and find little evidence to support it. Instead, our analysis suggests that the
overprojections are largely due to reductions in the rate of new infections in
the early to mid-1980s not accounted for in existing projections. In Section IV
we propose a new method for exploiting data on the rate of new infections and we
implement this method using data on two cohorts. The simple method we propose
clearly outperforms most other projections based on the techniques of back
calculation and extrapolation. Section V summarizes our results and offers some
suggestions for further research.
I. Methods of Projecting the Incidence of AIDS
Reported AIDS cases are the culmination of a series of events that begin
with specific individual behaviors including needle sharing among intravenous
drug users, engaging in heterosexual or homosexual sex, and receiving a blood
transfusion. Infection by the human immunodeficiency virus (HIV) is a
probabilistic outcome of these behaviors. The presence of the HIV (or, more
properly, antibodies to the HIV) can be detected in an individual's bloodstream
as early as four to six weeks after infection and will, if untreated, lead to
symptoms of AIDS as early as two years after infection. The onset of particular
symptoms, in combination with a positive test result, is required for a
physician to diagnose an individual as having AIDS and to report that diagnosis
to the state or local public health authority, which is responsible for
reporting it to the CDC.
One method of projecting AIDS cases, known as micro-simulation, attempts to
characterize statistically each stage of this process. Although projections of
AIDS cases on the basis of such a method have considerable intuitive appeal, the
utility of this technique is, as a practical matter, quite limited because many
key parameters necessary for its implementation are highly uncertain, such as
the size of the different sub-populations affected by the epidemic and rates of
interaction within and between those sub-populations (see Gail and Brookmeyer,
1988 and United States General Accounting Office, 1989). [1] More commonly,
projections of the incidence of AIDS are based on statistical methods that use a
more limited information set. Two such methods are now widely used:
extrapolation and back calculation. Both are described below (see Gail and
Brookmeyer, 1988; Brookmeyer, 1991; United States General Accounting Office,
1989; and Hellinger, 1990 for more detailed descriptions).
(a) Extrapolation
The simplest version of projection by extrapolation involves regressing a
time series of AIDS cases on a trend variable and using the estimated parameters
to generate projections of future cases. More complicated versions of this
method employ specifications that include nonlinear time trends or that use
nonlinear functions of the number of AIDS cases as the dependent variable.
Separate vectors of coefficients can be estimated for different subgroups of the
population (e.g., homosexual/bisexual men (HBM), intravenous drug users (IVDU),
etc.) and used to construct group-specific projections of the incidence of AIDS
that can then be combined to form refined aggregate projections.
The main advantages of extrapolation are its simplicity, its flexibility,
and the fact that it can be used to project the incidence of AIDS as far into
the future as one is willing to assume a continuing stable process. The main
disadvantage relates to this method's mechanical nature, which provides little
natural encouragement to think about and incorporate information directly
related to the underlying behavioral and epidemiological processes generating
AIDS cases.
(b) Back calculation
The method of projecting AIDS cases by back calculation proceeds in two
steps. First, a time series of new AIDS cases is mapped backwards into the
number of HIV infections that must have occurred in prior periods to generate
that time series. This "back calculation" is performed using independent
information on the distribution of time between infection with the HIV and the
emergence of AIDS symptoms. The most popular sources of information on this
"incubation distribution" are relatively small-sized samples of individuals in
particular transmission categories, with many cases that had yet to progress
from HIV infection to full-blown AIDS at the time that they were observed (see
Gail and Brookmeyer, 1988; United States General Accounting Office, 1989;
Brookmeyer and Liao, 1990; and Centers for Disease Control, 1990).
Second, the estimated time series of HIV infections (that is back
calculated from the time series of AIDS cases) is forward projected using the
incubation distribution to reconstruct the observed time series of AIDS cases
and to generate projections for future time periods. Projections constructed in
this manner will underestimate the number of future AIDS cases if new infections
occurred beyond the period for which infection rates can be inferred based on
the time series of AIDS cases. However, the fact that the proportion of cases
in which there is less than a two-year lag between HIV infection and symptomatic
AIDS is close to zero limits the extent to which new infections introduce error
into one- and two-year projections. For constructing projections further than
two years into the future, one could rely upon independent estimates of the
number of new infections. However, in practice, the number of new infections is
usually assumed to be zero, undermining the accuracy of the resulting
projections beyond two years into the future, potentially by large amounts. On
the other hand, and in contrast to the method of extrapolation, the method of
back calculation makes no assumptions at all about the stability of the
infection-generating process. (Table 1 illustrates the method of back
calculation with a simple hypothetical example.)
The accuracy of projections produced by the method of back calculation is
critically dependent on the quality and stability of data on the distribution of
delay between HIV infection and the onset of AIDS. Unfortunately, existing
estimates of the incubation distribution may be inaccurate because (1) they are
based on censored samples drawn years ago from a population distribution of
unknown form, (2) they may vary across transmission categories that have
themselves changed in relative importance over time, and (3) incubation
distributions for given transmission categories may be unstable over time,
especially since the advent of new drug therapies for the treatment of HIV
infection. Because AIDS projections are highly sensitive to the assumed
incubation distribution, these potential sources of error are serious weaknesses
of the method of back calculation. Indeed, most of the widely-used incubation
distributions produce estimates of negative numbers of infections in one or more
years, a patently absurd result that has led to the imposition of nonnegativity
constraints in recent applications of this method (see Hay and Wolak, 1990 and
Hellinger, 1990).
Projections based on the method of back calculation are particularly
sensitive to the incubation distribution because that distribution is used twice
in constructing the projections: first to back calculate the number of
infections and then to forward calculate the number of AIDS cases from the time
series of estimated infections. To illustrate this sensitivity, we perturb
slightly the hypothetical incubation distribution used in Table 1 and construct
a new projection of the number of AIDS cases for time period 9. The perturbed
distribution is as follows: 20 percent of individuals develop AIDS symptoms
three years after they are infected, 40 percent four years after infection, and
40 percent after five years. Using this perturbed distribution yields a
projection of 3700 cases for time period 9 (a 40 percent (average) deviation
between this projection and that based on the original incubation distribution).
II. Data and Methodological Issues
The preceding section described the two leading methods used to project the
number of AIDS cases. The discussion assumed that the data used to implement
these models are accurate measures of the number of AIDS cases diagnosed in each
period. Although CDC reporting of AIDS cases is remarkably complete and timely,
the AIDS case data are nonetheless imperfect in a number of ways that may have
important effects on the quality of the projections they inform.
To illustrate these problems, consider the following hypothetical system
for the surveillance of AIDS. On the day that every HIV-infected individual
first manifests symptoms of AIDS, he or she sees a physician who correctly
diagnoses his or her illness and reports the illness directly to the local or
state public health department, which immediately reports this information to
the CDC. Assume further that physicians make no incorrect diagnoses of AIDS and
that the criteria for diagnosing AIDS are unchanging over time.
Contrast this (almost ideal) AIDS surveillance system with the one actually
in place in the U.S. First, under the actual system there is a variable lag
between the onset of AIDS symptoms and the diagnosis of AIDS. Indeed, some
individuals suffering from AIDS may never be officially diagnosed as such,
perhaps because (1) they die from some opportunistic infection or other cause
before an AIDS diagnosis is made, (2) they and their physician suppress the true
diagnosis in an effort to avoid any stigma associated with being identified as
an AIDS sufferer, or (3) their physician fails to make a correct diagnosis.
Second, because incentives to comply promptly with AIDS reporting
requirements are weak, physicians (or the institutions with which they are
affiliated) do not, in practice, immediately report all AIDS diagnoses to state
public health departments and state public health departments do not immediately
report all AIDS diagnoses to the CDC. The time lag between the diagnosis and
reporting of an AIDS case is variable and may be lengthy, with some cases
perhaps never being reported.
Third, the criteria that must be met to justify an official AIDS diagnosis
have changed over time, with the number of symptoms generally being expanded and
the need for laboratory confirmation of AIDS symptoms being eliminated (see
United States General Accounting Office, 1989).
Under these circumstances, the CDC's time series of newly-diagnosed AIDS
cases will (1) understate the true number of AIDS cases (because some cases are
never diagnosed and some diagnoses are never reported); (2) understate the true
number of AIDS diagnoses (because some diagnoses are never reported while others
are reported with a delay); and (3) reflect inconsistent information over time
(if the delay distributions between the onset of symptoms, the physician's
diagnosis, and the CDC case report change over time or if the definition of AIDS
changes).
These features of the CDC's AIDS data must be considered when using those
data to project the national incidence of new AIDS cases. By comparing death
certificate records to CDC case reports, the extent of underreporting has been
estimated to be roughly 15 percent (with substantial regional variation, from 10
percent in major cities to 40 percent in low-prevalence areas; see Hardy, et al.
1987; Conway, et al. 1989; and Centers for Disease Control, 1990). Ideally,
reported AIDS cases can be inflated by this underreporting rate to generate
estimates of total cases. However, the underreporting rate may be unstable over
time, especially as physicians become more familiar with HIV/AIDS, less stigma
is attached to AIDS, Medicaid reimbursement rates for AIDS cases are increased,
states become more aggressive in their surveillance of AIDS, and the geographic
distribution of the disease shifts. Note also that the true number of AIDS
cases may also be understated by death certificate data.
Reporting delays are known to be lengthy in the case of AIDS. For example,
2.3 percent of cases diagnosed in 1982 and reported to the CDC through 1985 were
reported in 1985. Available data on the distribution of time between the
rendering of AIDS diagnoses and the receipt of AIDS case reports at the CDC can
be used to inflate cases reported into cases diagnosed. Unfortunately, the
distribution of reporting lags has been shown to be unstable over time, leaving
the accuracy of these adjustments in some doubt (Harris, 1990). To illustrate,
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4.3 percent of cases diagnosed in 1987 and reported to the CDC through 1990 were
reported in 1990 (an 85 percent increase from the 1982-85 example cited above).
[2] Furthermore, the delay between the onset of AIDS symptoms and the rendering
of an AIDS diagnosis is also unknown. Given the existence of life-prolonging
drug therapies for the treatment of AIDS, this delay is also likely to have
shortened over time, especially since reimbursement for the expense of those
drugs often requires a definitive AIDS diagnosis.
The CDC's adoption of an expanded AIDS case definition in 1987 led to an
estimated 18 percent increase in the number of reported AIDS cases (see Gail and
Brookmeyer, 1988 and Centers for Disease Control, 1990). In order to use pre-
and post-1987 data for projection, it is necessary to adjust them for
consistency before and after this definitional change, a complex task whose
handling has been, at best, imperfect (see Karon, Dondero, and Curran, 1988 and
Karon, Devine, and Morgan, 1989). Given the difficulties of adjusting the data,
some projections are based just on data recorded either before or after the
definitional change (see Gail and Brookmeyer, 1988 and Hellinger, 1988). [3]
The data problems described above all represent potential sources of
projection error. Underreporting will tend to lead to underprojections of the
true number of actual AIDS cases using both the methods of extrapolation and
back calculation but to accurate projections of reported AIDS cases unless the
extent of underreporting changes over time. For example, if the extent of
underreporting diminishes over time, projections based on either extrapolation
or back calculation are likely to overpredict the true number of reported AIDS
cases.
Reporting lags can introduce a wide range of errors into AIDS projections
whether those projections are constructed via extrapolation or back calculation.
However, the nature and magnitude of the errors will depend, in general, upon
the specific pattern of reporting lags and its stability over time.
Changes in the criteria used to define an AIDS case have complex and
uncertain effects on AIDS projections. Definitional changes are akin to a
reduction in underreporting in terms of their effect on the total number of
cases ever reported; they are also akin to a decline in reporting delay in terms
of their effect on the time pattern of diagnosed cases.
III. Review and Assessment of Earlier Projections
Table 2 summarizes the leading studies that report AIDS case projections
for 1991. The studies fall into two groups according to whether the projections
are based on the method of back calculation or extrapolation. All of the
projections reported in Table 2 refer to cases that would be diagnosed in 1991
(and that would eventually be reported to the CDC). In addition, all of the
studies base their projections on the CDC's monthly HIV/AIDS surveillance data.
Although most of the studies inflate their projections to account for the
underreporting of AIDS cases, those adjustments have been undone in the
preparation of Table 2 in order to report figures that are comparable to the
number of AIDS cases that will ultimately be reported as having been diagnosed
in 1991. All of the projections are based on data that have been adjusted for
reporting delays, although the methods used to make those adjustments vary
across the studies. Finally, four of the five studies in Table 2 are based on
the pre-1987 AIDS case definition.
The third and fourth columns of Table 2 report projections from each study
of the number of AIDS cases that would be diagnosed in 1991. The third column
reports each study's actual projection for 1991, after removing the effect of
any adjustment for underreporting made in the study. The fourth column adjusts
these figures so that they represent projections of the number of diagnosed AIDS
cases in 1991 based on the post-1987 case definition (i.e., the adjustment is
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made by multiplying the projections in column three by 1.18, following Gail and
Brookmeyer, 1988).
The projections reported in Table 2 range from 53,000 to 89,000 cases
(adjusted for the 1987 case definition change). This range exceeds by 15 to 93
percent our estimate of the actual number of cases that were diagnosed in 1991
and will ever be reported (i.e., 46,000). [4, 5, 6]
Figure 1 plots monthly AIDS cases from 1982 to 1990, along with a
projection curve from 1987 to the end of 1990. The data plotted have been
adjusted by the CDC for reporting delay (as of June, 1991). The projection
curve is derived by regressing these data from 1982 through the end of 1986 on a
quadratic function of time (i.e., a standard extrapolation model). Figure 2
presents a similar plot using quarterly AIDS case data that have been adjusted
by the CDC for the 1987 change in the AIDS case definition. (These plots of
"definitionally consistent cases" cover the period from the first quarter of
1983 through the third quarter of 1990, with the regression line estimated using
data through the fourth quarter of 1986.) [7]
Figures 1 and 2 illustrate graphically that the extrapolation method leads
to overprojections of the number of AIDS cases, with the divergence becoming
quite substantial by 1990. Although not shown in these figures, extrapolation
models based on more elaborate specifications (e.g., such as those reported in
Hellinger 1988; United States General Accounting Office, 1989; and Hellinger,
1990) show a similar pattern.
To gain further insight into the origin of the projection errors revealed
in Figures 1 and 2, we examine two studies that report AIDS case projections for
specific transmission categories. Brookmeyer and Damiano, 1989 (which bases its
projections on back calculation, assuming no new infections after 1987) and
Morgan and Curran, 1986 (which bases its projections on extrapolation), both
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overpredict the share of AIDS cases involving HBMs and underpredict the share of
AIDS cases involving IVDUs that would occur in 1991. [8] Morgan and Curran also
report projections for specific regions in 1991. They overproject the
proportion of AIDS cases occurring in San Francisco, where HBM is the dominant
transmission category, and underproject the share of cases in New York City and
Florida, where the dominant transmission category is IVDU.
Figures 3a, 3b, and 3c plot monthly AIDS cases from 1982 through 1990 for
three transmission categories: HBMs, blood transfusion and blood products cases
(BTBP), and IVDUs. [9] Figures 4a, 4b, and 4c plot quarterly data on
definitionally consistent AIDS cases. The plots in Figures 3 and 4 reveal quite
clearly that the flattening of the time series of all AIDS cases was associated
most closely with a leveling off in the number of cases involving HBM and BTBP
that appears to have begun in mid-1987. [10] Indeed, quadratic projection
curves fit separately to the monthly and quarterly data for the three
transmission categories indicate that the largest source of overall error is due
to HBM. Tests for the stability of these time-series regressions before and
after the beginning of 1987 are reported in Table 3, using both the monthly and
quarterly data. All of the tests for the HBM, BTBP, and IVDU cases lead to
rejections of the null hypothesis of stability. [11] These findings undermine
the confidence that can be placed in the extrapolation method because they
suggest that the fundamental premise of stability upon which this method is
based is violated. [12]
IV. Explaining the Forecast Errors
The preceding section demonstrated that extrapolation models, widely used
for constructing AIDS case projections (1) have unstable parameters, (2) have
led to sizable overprojections of the number of AIDS cases, and (3) have
provided especially poor projections for HBM and BTBP cases, as early as 1987.
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We also showed that back calculation models, which are inherently limited in
their ability to project more than two or three years into the future, have
tended to overproject the number of AIDS cases, sometimes by sizable amounts.
There are two natural explanations for this pattern of forecast errors: (1)
changes in the availability and use of drug therapies for the treatment of
asymptomatic HIV infection (Gail, Rosenberg, and Goedert, 1990) and (2) changes
in behaviors that are associated with the rate of occurrence of new infections.
[13] Both explanations are examined empirically in the sections below, in the
interest of improving the basis on which one can project AIDS cases.
A. Effects of AZT Usage
It is now generally believed that the use of AZT delays the onset of AIDS
symptoms among HIV-infected individuals (i.e., "the risk of progression to AIDS
among treated patients is approximately one-third the risk for untreated
patients"; Centers for Disease Control, 1990, p. 15). The use of AZT as a
prophylactic against the progression to AIDS began around 1987. In that year,
approximately 7 percent of HIV-seropositive non-AIDS members of the Multicenter
AIDS Cohort Study received some drug therapy to inhibit the onset of AIDS
symptoms. In 1989, 73 percent of HBM in the San Francisco Clinic Study who
would most benefit from AZT treatment received AZT (see Centers for Disease
Control, 1990 and Hellinger, 1990). Although the increase from 7 to 73 percent
from 1987 to 1989 likely overstates the true rise in the rate of increase in the
use of AZT for the seropositive population at large (because HBM have relatively
good access to knowledge about the latest prophylactic therapies and because the
latter estimate focuses on a sample of highly-selected individuals), it is
useful to explore the implications of these statistics for the time-series
pattern of AIDS cases. [14]
Our analysis involves (1) converting the Weibull incubation distribution
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reported in Gail and Brookmeyer (1988) into a hazard function, introducing the
effect of AZT by (2) constructing a new hazard function for the progression to
AIDS that is one-third the level of that reported in Gail and Brookmeyer (1988);
(3) working backwards from that new hazard function to the implied density
function for the delay between infection and symptoms (see Figure 5 for a
comparison of the pre- and post-AZT density functions for the delay between
infection and symptoms); (4) applying the modified density function to the time-
series of newly-infected individuals estimated by Taylor (1989), for the
fraction of individuals assumed to be using AZT (linearly interpolated for
1988); and (5) comparing the time-series of future AIDS cases (forward-
calculated) between the two incubation distributions.
The results of this analysis are displayed in Figure 6. They indicate that
the use of AZT by seropositive asymptomatic individuals could have accounted for
a substantial short run reduction in the growth rate of the number of AIDS
cases. This reduction should be interpreted as a likely upper bound on the true
decrease since it is based on estimates of the level and growth of AZT usage
that are likely upward biased.
Our results also indicate that the effect of AZT is to postpone cases,
giving rise to a notch in the time-series of cases (i.e., the leveling that
starts in 1987 followed by a steepening about two years later). Although the
use of AZT might help explain the overprojections following 1986, the timing
pattern suggested in Figure 6 is not readily apparent in the time series plots
in Figures 1 and 2 of either all cases or definitionally consistent cases. This
last result is not sufficient to reject the importance of AZT to the generation
of AIDS case data because of the possible presence of other confounding
influences (e.g., changes in new infection rates, changes in the pattern of AZT
usage over time, particular instabilities in the distribution of reporting
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delays, definitional changes, or AZT not having such a large effect or a
different pattern of effect at each stage, etc.)*
To explore further the importance of AZT, we can reexamine the data for a
particular transmission category: HBM. The results, which are displayed in
Figure 3a, are quite striking insofar as the leveling of new cases appears to
have predated the widescale use of AZT by as much as two years. This finding
does not support the importance of AZT usage as an explanation for
overprojections of the incidence of new AIDS cases. [15]
While there is little evidence that the use of AZT has affected the time
series of AIDS cases, there is some evidence that AZT and other prophylaxis,
particularly aerosolized pentamidine (which was introduced at about the same
time as AZT), have had an impact on the survival time of AIDS patients. This
finding is apparent in a comparison of death rates over time between the HBM and
IVDU transmission categories (see Figures 7a and 7b). The series for HBM shows
a marked flattening between 1987 and early 1988, when AZT came into heavy use,
unlike the steady growth of deaths among IVDUs, who have a considerably lower
usage rate of AIDS drugs than HBM (see Centers for Disease Control, 1990).
B. Effects of Changes in Hiqh-Risk Behavior
AIDS projections based on empirical extrapolation all rely on the time-
series of diagnosed AIDS cases reported to the CDC, adjusted for reporting
delay. This time series embodies information on behavioral change, but with a
long and variable lag because the mean of the incubation distribution is over
eight years. However, independent information on changes in behavior is
available and can possibly be used to improve the accuracy of AIDS projections.
To illustrate the use to which such information can potentially be put, we
propose a method that uses independent data on the time series of HIV
infections. The empirical strategy is to apply an AIDS incubation distribution
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to these infection data to develop an index that reflects the time pattern of
AIDS cases. Regression parameters are then estimated that link this index to
the time series of actual AIDS cases. These parameters can then be applied to
the values of the AIDS case index in future periods to project future AIDS
cases. We implement this method using readily available and well-known data for
two risk groups.
The infection data used in this illustration are for cohorts of individuals
whose serostatus has been monitored since before the beginning of the epidemic
and who have been tested annually for HIV infection. The two longest-running
studies are the San Francisco Cohort Study of Gay Men and the Hershey Hemophilia
Cohort Study. [16] The time-series of new infection rates for each cohort are
reported in Table 4. These data indicate that the rate of new infection
declined sharply in and after 1983 for HBM; the results for hemophiliacs show
that HIV infection had saturated the population by 1985, after which the U.S.
blood supply was effectively screened for the HIV. These patterns in rates of
new infection would not manifest themselves significantly in patterns of new
AIDS cases until the second half of the 1980s. Failure to account for this
decline could lead to sizable projection errors.
The information on rates of new infection in Table 4 is used to construct
an AIDS Case Index (ACI) by using the incubation distribution (i.e., the Weibull
distribution in Figure 5, without AZT) to forward calculate AIDS cases from HIV
infections. These indexes are reported in columns 2 and 4 in Table 4.
Before examining the results of analyses based on these indexes, their
limitations should be noted. First, the degree to which the San Francisco
cohort is representative of the U.S. population of HBM is uncertain. The San
Francisco cohort is likely to have been better informed about the risks of
different behaviors, available treatments, etc. In addition, the epidemic began
earlier in San Francisco than in the rest of the U.S. Notwithstanding these
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differences, the post-1983 rates of new infection among HBM cohorts in San
Francisco are generally near the median of corresponding rates for other HBM
cohorts elsewhere in the U.S. (Centers for Disease Control, 1987).
Second, the degree to which the Hershey Hemophilia cohort is representative
of the entire U.S. population of users of blood and blood products is also
questionable, mainly because the Hershey cohort is exceedingly small in size and
is limited to severe hemophiliacs. Also, the U.S. blood supply began to be
informally screened (with blood banks asking prospective blood donors about
behavior that might have put them at high risk for contracting the HIV) as early
as 1983, which could have affected the rate of new infection due to blood
transfusions. However, this type of informal screening would not have reduced
to the same extent the probability of infection among severe hemophiliacs who
received clotting factor derived from the blood of many individuals.
Third, using the ACI to project AIDS cases more than two years into the
future requires one to make an assumption about the future time series of new
infections. In the example below, we have assumed a stable rate of new
infection for HBM of 0.8 percent per year.
These potential limitations of the AIDS Case Indexes in Table 4 can be
assessed empirically by seeing how closely the various historical time series'
of AIDS cases have moved with these indexes. Table 5 reports time-series
regressions of the number of AIDS cases (adjusted by the CDC for reporting
delay) on the appropriate ACI. Estimates are reported separately for (1) the
time periods 1982-86 and 1982-90, (2) HBM and BTBP cases, and (3) diagnosed
cases and definitionally consistent cases. [17]
The results in Table 5 are consistent with the hypothesis that the ACI
contains useful information about the time series pattern of AIDS cases. All of
the index coefficients are positive and the R-squared estimates are quite high
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(and higher in magnitude than those that result from corresponding time-series
regressions of AIDS cases on a linear time trend). Also, in contrast to the
quadratic trend regressions in Table 3, in which the coefficients changed
sizably and significantly between sub-periods, the coefficients appear
remarkably stable between 1982-86 and 1982-90, an indication that the ACI models
are appropriate. When we allow a linear time trend and the appropriate ACI to
"fight it out" in the same regression specification over the 1982-90 period, the
trend coefficient always falls sharply in magnitude (sometimes changing sign)
while the ACI coefficient exhibits relatively modest changes (always remaining
positive). These findings suggest that the ACI model is reasonably robust with
respect to a simple change in specification. [18]
Figures 3a, 3b, 4a, and 4b plot (1) CDC data on the time series of HBM and
BTBP AIDS cases (available monthly) and HBM and BTBP consistent cases (available
quarterly) from 1982 to 1990; (2) projected cases in each category based on a
time-series regression of case counts on a quadratic trend; and (3) fitted and
projected cases based on a time-series regression of case counts on the ACI from
1982 to 1986 and projected using the ACI from 1987 to 1990.
The results in Figures 3a, 3b, 4a, and 4b provide a strong indication that
AIDS projections can be dramatically improved by exploiting knowledge about the
process generating the data: that HIV infections (about which some information
is available) lead to AIDS cases according to a lag distribution (about which
some information is also available). For HBM cases, the projection errors for
1990 that result from a standard extrapolation model are four to eight times
larger (in absolute value) than those that emerge from the ACI model; for BTBP
cases they are five to eight times larger. [19]
18
V. Conclusion
To illuminate the potential importance of our empirical findings, we have
constructed several crude projections of numbers of new AIDS cases in 1994 and
1995. These projections, which refer to diagnosed cases that will ever be
reported to the CDC, are presented in Table 6. The projections in the first
panel are based on a quadratic extrapolation model applied to monthly CDC data
on all AIDS cases from 1982 through 1990 (adjusted for reporting delay by the
CDC and for the September 1987 case definition change by the inclusion of a
shift parameter, but not adjusted for underreporting). The projections in rows
two through four are derived by fitting a similar model to case data for the
three transmission categories indicated. The fifth row is a projection of cases
due to other forms of transmission, derived by subtracting projected HBM, BTBP,
and IVDU cases from the projection for All Cases. [20]
The projections in the second panel are based on the AIDS Case Index in
Table 4, constructed separately for HBM and BTBP cases. The final row in Table
6 reports a Composite (ACI-Extrapolation) Projection, constructed by adding the
ACI projections for HBM and BTBP Cases to the extrapolation-based projections
for IVDU Cases and Other Cases (since we have not constructed an ACI for either
of these latter transmission categories and since Figure 3c suggests that the
extrapolation method results in relatively small projection errors when fit to
IVDU cases).
There are two noteworthy features of the projections in Table 6. First,
the standard extrapolation method projects a 72 percent increase in the number
of new cases between 1991 and 1995 (with a 10 percent increase from 1994 to
1995). By contrast, the composite projection suggests only a 24 percent
increase in AIDS cases from 1991 to 1995 (with a four percent increase from
1994 to 1995). The extrapolation method projects 22,000 more new cases in 1995
than the composite method.
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Second, the extrapolation method projects HBM as the dominant AIDS
transmission category in 1994 and 1995, whereas IVDU will be the dominant
category according to the composite projection. This difference has important
policy ramifications with respect to the control of the epidemic insofar as it
suggests that efforts aimed at the prevention, detection, and treatment of
HIV/AIDS need to be focussed on a fundamentally different social and economic
population, concentrated in different areas of the U.S. This result also
highlights the finding that behavioral change among homosexual/bisexual males in
the U.S. seems to have been substantial enough to dramatically alter the course
of the epidemic within that community.
Our composite projections could be further refined by utilizing other
sources of information on (or correlated with) rates of new infection among HBM
and BTBP, adjusting available infection data to improve the degree to which they
represent the entire HBM and BTBP populations, and gathering data related to
rates of new infection among IVDUs and other transmission categories (even for
relatively small samples of individuals), and for specific demographic groups
and geographic locations (see Bloom and Glied, 1992). Nonetheless, our analysis
has shown that even the crude ACI method we use to project new AIDS cases
outperforms the extrapolation method, as judged by historical data for two
transmission categories. The figures in Table 6 show further that different
projection methods can lead to substantially different projections, even as few
as four to five years into the future. Taken together, these findings confirm
the importance of paying attention to the process generating the data series for
which projections are desired.
The literature on AIDS projections has exhibited a preoccupation with
statistical issues related to adjustments for underreporting, reporting delay,
and changes in the AIDS case definition, and to the choice of functional form in
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extrapolation equations and the imposition of non-negativity constraints in back
calculation. Although we do not deny the importance of these and other
statistical issues, our results suggest that relatively greater improvements in
projection accuracy can be realized by attention to underlying behavioral
processes and through the incorporation of additional readily available data
into AIDS case projections. Our results suggest that further application of the
ACI model can dramatically improve the accuracy of the next generation of AIDS
projections and the basis on which individual behavior and related public and
private policies are determined.
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Notes
1. But see Lemp, Payne, and Rutherford, 1990 for an example of a micro-
simulation model that provides highly accurate AIDS case projections for San
Francisco.
2. See Harris, 1990 for an in-depth analysis of reporting delays and changes in
their distribution over time.
3. See Centers for Disease Control (1989) for a review of changes that occurred
in the AIDS case definition prior to 1987. Note also that another major
definitional change due to have taken effect in January 1992 was postponed
indefinitely to allow for further study of the impacts of the proposed
change.
4. Diagnosed cases from 1991 were estimated by examining the ratio of cases
diagnosed and reported in 1987 to cases diagnosed in 1987 and reported by
the end of 1991. That ratio, 55 percent, was then applied to cases
diagnosed and reported in 1991 to estimate the number of 1991 diagnosed
cases that would ultimately be reported by the end of 1995. Other
calculations we performed suggest this is a reasonable estimation procedure.
5. The low end of this projection range, the Brookmeyer and Damiano lower bound
projection, is based on three critical assumptions: that no new infections
occur after 1987, that AZT becomes very widely used by 1991 among
asymptomatic HIV-infected individuals, and that the use of AZT delays the
onset of symptoms among seropositive individuals who are asymptomatic.
However, there is considerable evidence that HIV infections continued to
occur after 1987 and that AZT is not widely used by all groups of
asymptomatic HIV-infected individuals (Centers for Disease Control, 1990).
Thus, the Brookmeyer and Damiano lower bound projection comes closest among
the studies in Table 2 to predicting the actual number of new cases in 1991,
but not because the assumptions upon which that projection is based are
closely satisfied.
6. The Hay and Wolak (1990) study utilizes data from before and after the AIDS
case definition changed in September 1987, without adjusting for the effect
of the definitional change on the underlying data used to construct their
projections. According to Gail and Brookmeyer (1988) this definitional
change, which mainly involved a weakening of the criteria that had to be
satisfied for a physician to render a diagnosis of AIDS, caused roughly an
18 percent increase in the number of AIDS cases that would ever be reported
to the CDC. The definitional change presumably affected the timing of AIDS
case reports as well, resulting in a temporary upsurge of cases in the
period immediately following the change. Despite this limitation, Hay and
Wolak's projection of 1991 cases (44,000) comes very close to our estimate
of diagnosed cases for that year (46,000).
7. We are grateful to John M. Karon of the CDC for providing us with these
data, which also embody the CDC adjustment for reporting delay. Note that
consistent cases do not refer to either the AIDS case definition in effect
before or the definition in effect after the September 1987 definitional
change; rather, they refer to a distinctly different definition that can be
consistently applied during both time periods.
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8. Brookmeyer and Damiano report projections of cumulative AIDS cases through
the end of 1991; Morgan and Curran report projections of new cases in 1991.
9. The HBM category excludes cases in which intravenous drug use is also a risk
factor; the IVDU category does not include any cases in which HBM is a risk
factor.
10. The fact that the leveling off began later in the monthly case data than in
the quarterly data on consistent cases supports the notion that the case
definition change had an effect on the timing of cases.
11. This result is also upheld using 1986 or 1988 as the break points.
12. We also explored the use of the following logistic growth curve to model
the time series of cases: Y. = a/(l+exp(c+d )). Although this curve
provides a reasonably good fit to data on all cases, as well as cases by
transmission category, it does not perform as well as the quadratic
specification in out-of-sample projections. The results are available from
the authors upon request.
13. This conclusion assumes reasonably stable patterns of underreporting and
reporting delays and that the effects of case definition changes have been
accounted for adequately.
14. For other discussions of the effect of using AZT and its impact on the
pattern and count of AIDS cases see Brookmeyer and Liao, 1990; Hellinger,
1990; Gail and Brookmeyer, 1990; and Gail, Rosenberg, and Goedert, 1991.
15. Even if AZT has a small aggregate effect, failure to account for its use
could lead to large errors in projections based on back calculation because
of the sensitivity of that method to estimates of the incubation
distribution.
16. Both cohort studies are discussed in Centers for Disease Control, 1987.
17. Since they map the ACI, which applies to a sample of known size, into
numbers of AIDS cases in a population of unknown size (that is assumed to
be fixed), the regression coefficients in Table 5 could, in principle, be
used to estimate the sizes of the relevant transmission populations. The
validity of this technique rests on the assumption that the prevalence of
HIV infection at each point in time is equal between the sample and the
population. This assumption of equality is not, however, necessary for the
ACI to generate accurate projections of AIDS case counts. Rather, it is
necessary only that the ratio of new infections in the sample and the
population is roughly constant over time. Our results suggest that the
prevalence of infection in the San Francisco cohort and in the Hershey
Hemophilia cohort are greater than the prevalence of infection in the
corresponding HBM and BTBP populations of the U.S.
18. Unfortunately, the small number of data points, due to the fact that the
index is only available on an annual basis, precludes our constructing a
meaningful test for the stability of the coefficients. The small number of
data points also precludes our performing the necessary corrections for
serial correlation that would enable us to report significance tests for
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the trend and ACI coefficients.
19. The ACI method of projection is far less sensitive to estimates of the
incubation distribution than the method of back calculation because it uses
that distribution only once in constructing projections. For example,
applying the ACI method to the hypothetical example in Table 1 yields a
projection of 5500 cases for time period 9 using the original incubation
distribution and a projection of 5200 cases using the perturbed
distribution (an (average) deviation of less than 6 percent, in contrast to
the nearly 40 percent deviation for projections based on back calculation).
20. We have not constructed projections based on the method of back calculation
because 1994 and 1995 are too far into the future to generate meaningful
projections using this method.
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Results of Extrapolation Projections
(all figures adjusted for reporting delay using CDC weights)








HBM Cases 82-86** 47.58
HBM Cases 82-90 -238.66
***
BTBP Cases 82-86 2.78































































































* The F-statistic is reported as a test of the hypothesis that the coefficient vector is stable before and
after 1987. The critical value at the 95 percent confidence level for monthly cases is 3.98; the critical
value at the 95 percent confidence level for quarterly cases is 4.68. The unconstrained results are
available from the authors upon request.
** Homosexual/bisexual men who are not intravenous drug users.
*** Blood transfusion/blood products cases.
**** Consistent case estimates are for CDC data adjusted to include only cases that would have met
the pre-1987 case definition. These data do not include children, Pattern II, and "No Identified Risk"
cases. (Karon, 1991). These data end in the third quarter of 1990.









































































































* Homosexual/bisexual men who are not intravenous drug users.
** Blood transfusion/blood products cases.
(1) The incubation distribution used to construct the AIDS case index is based on Brookmeyer and Gail's
(1989) estimate of the cumulative distribution for the transition to AIDS: F(t) = 1 -exp(-.004r- 3 8 ) where t
represents the delay (in years) between infection and the emergence of AIDS symptoms and F() is the
cumulative distribution function for a Weibull variate.
(2) The infection distribution represents the percent of initially seronegative individuals in a well-defined
cohort who became infected in each calendar year. The homosexual/bisexual infection distribution uses
information from a San Francisco cohort consisting of 283 individuals. The blood products infection
distribution uses information from the Hershey Hemophilia cohort of 30 individuals. (CDC, 1987) Since the
infection distribution reported in CDC, 1987 for homosexual/bisexual men ends in 1986, we have assumed that
it remained constant at 0.8 persons per year thereafter. Heat treatment of blood products and testing of the
blood supply were implemented in 1985, implying few BTBP infections after 1985. In this connection, note that
the Hershey cohort was 100 percent infected by the end of 1984.
(3) The case indices are constructed by applying the incubation distribution to the infection rate in each year
and then summing AIDS cases across infection cohorts to estimate a case index by year.
Table 5
Results from Index Based Projections










































* Homosexual/bisexual men who are not intravenous drug users.
** Blood transfusion/blood products cases.
*** Consistent case estimates are for CDC data adjusted to include only cases that would have met the
pre-1987 case definition. These data do not include children, Pattern II, and "No Identified Risk" cases.
(Karon, 1991). These data end in the third quarter of 1990.
TABLE 6
Selected Projections of AIDS Cases
in 1994 and 1995
Extrapolation 1994 1995
Method1
All Cases 72,000 79,000
HBM Cases 32,000 34,000
BTBP Cases 1,000 -0-
IVDU Cases 20,000 23,000
Other Cases2 19,000 22,000
ACI Method3
HBM Cases 15,000 11,000
BTBP Cases 1,000 1,000
Composite
Projection
All Cases4 55,000 57,000
1 The extrapolation estimates for All Cases, HBM Cases, BTBP Cases, and IVDU Cases are based on
the estimated coefficients of a quadratic trend fit to monthly data for 1982-90 as reported in Table
3, with an intercept shift following the change in the AIDS case definition that occurred in
September, 1987. All figures in this table are rounded to the nearest thousand.
2 The estimate for Other Cases is equal to the difference between the extrapolation estimate for All
Cases and the sum of the extrapolation estimates for HBM, BTBP, and IVDU Cases.
3 The ACI estimates for HBM and BTBP Cases are calculated by applying the estimated coefficients
from the ACI fit to monthly data for 1982-90 (reported in Table 5) to the ACI values for 1994 and
1995 for HBM and BTBP Cases (reported in Table 4).
4 The Composite Projection is constructed by adding the ACI projection of HBM and BTBP Cases to
the extrapolation projection for IVDU and Other Cases.
Figure 1
Monthly AIDS Cases
(adjusted for reporting delay)
number of cases (thousands)
1982 | 1983 | 1984 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990
year
+ Projected Cases: Quadratic Trend
Actual Cases
Source: Centers for Disease Control
Figure 2
Quarterly AIDS Cases Based on Consistent Case Definition
(adjusted for reporting delay)
number of cases (thousands)
0
1983 1984 1985 1 986 1987
year
1988 1989 1990
+ Projected Cases: Quadratic Trend
* Actual Cases
Source: J.M. Karon, unpublished.
Figure 3a
Monthly AIDS Cases: HBM
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Source: Centers for Disease Control
Figure 3b
Monthly AIDS Cases: BTBP
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Figure 3c
Monthly AIDS Cases: IVDU
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Figure 4a
Quarterly AIDS Cases Based on Consistent Case Definition: HBM
(adjusted for reporting delay)
number of cases (thousands)
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1983 | 1984 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990
year
+ Projected HBM Cases: AIDS Case Index
Actual HBM Cases ^Projected HBM Cases*
* Quadratic Trend
Source: J.M. Karon, unpublished.
Figure 4b
Quarterly AIDS Cases Based on Consistent Case Definition: BTBP
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Figure 4c
Quarterly AIDS Cases Based on Consistent Case Definition: IVDU
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Figure 5














Effect of AZT on the Time Series of AIDS Cases
(assumes no new infections after 1987)
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